Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

JUXTAPID vs KETAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

JUXTAPID vs KETAMINE: Safety Overview

Metric JUXTAPID KETAMINE
Total FAERS Reports 179 7,993
Deaths Reported 2 1,009
Death Rate 1.1% 12.6%
Hospitalizations 13 3,362
Average Patient Age 58.0 yrs 41.0 yrs
% Female Patients N/A 46.7%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Eugia US LLC
Route N/A INTRAMUSCULAR
Marketing Status N/A Prescription